UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus

UK stereotactic ablative radiotherapy trials normal tissue dose constraints tolerance consensus

Bibliographic Details
Main Authors:	Hanna, G, Patel, R, Aitken, K, Jain, S, Franks, K, Van As, N, Tree, A, Harrow, S, Eaton, D, McDonald, F, Ahmed, M, Saran, F, Webster, G, Khoo, V, Landau, D, Hawkins, M
Format:	Conference item
Published:	Elsevier 2016

Similar Items

UK consensus on normal tissue dose constraints for stereotactic radiotherapy
by: Hanna, G, et al.
Published: (2017)

Stereotactic body radiotherapy for liver metastases.
by: Aitken, K, et al.
Published: (2015)

Stereotactic body radiotherapy for oligometastases.
by: Tree, A, et al.
Published: (2013)

A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
by: Khoo, V, et al.
Published: (2018)

CORE: A randomised trial of COnventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases
by: Khoo, V, et al.
Published: (2017)

CORE: A randomised trial of COventional care versus Radioablation (stereotactic body radiotherapy) for Extracranial oligometastases
by: Khoo, V, et al.
Published: (2017)

Pelvic re-irradiation using stereotactic ablative radiotherapy (SABR): A systematic review.
by: Murray, L, et al.
Published: (2017)

The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC)
by: Moreno-Olmedo, E, et al.
Published: (2024)

Initial UK Experience of Stereotactic Body Radiotherapy for Extracranial Oligometastases: Can We Change the Therapeutic Paradigm?
by: Aitken, K, et al.
Published: (2015)

Stereotactic Radiotherapy for Renal Denervation
by: Mahfoud, Felix, et al.
Published: (2020)

Four-dimensional computed tomography contouring variability in stereotactic body radiotherapy of non-resectable biliary tract cancer
by: Robinson, M, et al.
Published: (2017)

Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
by: Tse, R, et al.
Published: (2008)

The role of technology in clinical trials using stereotactic body radiotherapy.
by: Aznar, M, et al.
Published: (2017)

Robotic Stereotactic Body Radiotherapy for Spine Metastasis Pain Relief
by: Rivas, D, et al.
Published: (2024)

Stereotactic radiotherapy of benign meningioma in the elderly: clinical outcome and toxicity in 121 patients.
by: Fokas, E, et al.
Published: (2014)

Conformity analysis to demonstrate reproducibility of target volumes for Margin-Intense Stereotactic Radiotherapy for borderline-resectable pancreatic cancer.
by: Holyoake, D, et al.
Published: (2016)

Stereotactic Body Radiotherapy: is less fractionation more effective in adrenal and renal malignant lesions?
by: Rivas, D, et al.
Published: (2024)

Optimising stereotactic body radiotherapy for non-small cell lung cancer with volumetric intensity-modulated arc therapy--a planning study.
by: Brock, J, et al.
Published: (2012)

A brain metastasis therapy tweak, for the better? Concomitant stereotactic radiotherapy and molecular-targeted therapy
by: Soto, M, et al.
Published: (2017)

Stereotactic inverse dose planning following yttrium-90 selective internal radiotherapy in hepatocellular cancer
by: Abbott, EM, et al.
Published: (2020)

STEREOTACTIC LASER ABLATION OF HIPPOCAMPUS LEADS TO BETTER COGNITIVE OUTCOME THAN STANDARD TEMPORAL LOBE RESECTION FOR THE TREATMENT OF EPILEPSY
by: Drane, D, et al.
Published: (2013)

SPARC: A phase-I trial of pre-operative margin-intensified stereotactic radiotherapy for pancreatic cancer at high risk of positive resection margins
by: Holyoake, D, et al.
Published: (2018)

EP-1981: Clinical delivery of stereotactic radiosurgery using a linac with 5 mm MLC
by: Padmanaban, S, et al.
Published: (2018)

Organ-sparing Intensity-modulated radiotherapy for anal cancer using the ACTII schedule: a comparison of conventional and intensity-modulated radiotherapy plans.
by: Brooks, C, et al.
Published: (2013)

Stereotactic radiotherapy for neovascular age-related macular degeneration (STAR): a pivotal, randomised, double-masked, sham-controlled device trial
by: Jackson, TL, et al.
Published: (2024)

Asian australasian society of stereotactic and functional neurosurgery
by: Idris, Zamzuri
Published: (2012)

Cone beam computed tomography-derived adaptive radiotherapy for radical treatment of esophageal cancer.
by: Hawkins, M, et al.
Published: (2010)

Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas.
by: Swords, F, et al.
Published: (2003)

Stereotactic body radiation therapy for painful spinal metastases - Results of a phase 2 study
by: Guckenberger, M, et al.
Published: (2018)

Set-up errors in radiotherapy for oesophageal cancers--is electronic portal imaging or conebeam more accurate?
by: Hawkins, M, et al.
Published: (2011)

Target identification for stereotactic thalamotomy using diffusion tractography.
by: Kincses, Z, et al.
Published: (2012)

On the Cost of Fault-Tolerant Consensus When There Are No Faults - A Tutorial
by: Keidar, Idit, et al.
Published: (2023)

Awake stereotactic biopsy of brain stem lesions: technique and results
by: Shad, A, et al.
Published: (2005)

Awake stereotactic biopsy of brain stem lesions: technique and results.
by: Shad, A, et al.
Published: (2005)

Superior verbal memory outcome after stereotactic laser amygdalohippocampotomy
by: Drane, DL, et al.
Published: (2021)

Dose-intensified hypofractionated stereotactic body radiation therapy for painful spinal metastases: Results of a phase 2 study
by: Guckenberger, M, et al.
Published: (2018)

Stereotactic radiation therapy for benign meningioma: long-term outcome in 318 patients.
by: Fokas, E, et al.
Published: (2014)

A “eye-in-body” integrated surgery robot system for stereotactic surgery
by: Li, Liang, et al.
Published: (2021)

Stereotactic neurosurgery in the United Kingdom: the hundred years from Horsley to Hariz.
by: Pereira, E, et al.
Published: (2008)

Effects on cognition of stereotactic lesional surgery for the treatment of tremor in multiple sclerosis.
by: Jahanshahi, M, et al.
Published: (2008)